| Net Cash Provided by (Used in) Operating Activities |
$6,720,000 |
USD |
-125% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,324,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$328,000 |
USD |
-97% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
35,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2,002,568 |
shares |
50% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,721,000 |
USD |
-1906% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$35,573,000 |
USD |
13426% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$47,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$58,852,000 |
USD |
11% |
Q4 2024 |
|
| Deferred Tax Assets, Gross |
$58,974,000 |
USD |
9.9% |
Q4 2024 |
|
| Operating Lease, Liability |
$518,000 |
USD |
-3.7% |
Q4 2024 |
FY 2024 |
| Depreciation |
$300,000 |
USD |
-40% |
Q3 2024 |
Q3 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$2,000 |
USD |
-97% |
Q1 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$1,946,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Property, Plant and Equipment, Gross |
$1,655,000 |
USD |
-29% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$261,000 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$654,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$789,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.1 |
pure |
27% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$190,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$309,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$48,662,000 |
USD |
37% |
Q4 2024 |
|
| Preferred Stock, Shares Authorized |
2,895,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$1,191,000 |
USD |
|
Q4 2024 |
|
| Additional Paid in Capital |
$338,914,000 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$122,000 |
USD |
-71% |
Q4 2024 |
|
| Share-based Payment Arrangement, Expense |
$1,400,000 |
USD |
-40% |
Q3 2024 |
Q3 2024 |
| Interest Expense |
$1,400,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |